Daré Bioscience, Inc. Analyst EPS Estimates
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 1 | -$0.72 | -$0.72 | -$0.72 |
Q2 2024 | 0 | -$0.04 | -$0.04 | -$0.04 |
Q3 2024 | 2 | -$0.75 | -$0.62 | -$0.69 |
Q4 2024 | 0 | -$0.50 | -$0.50 | -$0.50 |
Q1 2025 | 1 | -$0.14 | -$0.14 | -$0.14 |
Q2 2025 | 1 | -$1.34 | -$1.34 | -$1.34 |
Q3 2025 | 1 | $0.04 | $0.04 | $0.04 |
Q4 2025 | 1 | $0.43 | $0.43 | $0.43 |
Daré Bioscience, Inc. Earnings Date And Information
Daré Bioscience, Inc. last posted its earnings results on Monday, August 12th, 2024. The company reported $1.52 earnings per share for the quarter, topping analysts' consensus estimates of $-0.57 by $2.09. The company had revenue of 22,438 for the quarter and had revenue of 2.81 M for the year. Daré Bioscience, Inc. has generated $-4 earnings per share over the last year ($-4.15 diluted earnings per share) and currently has a price-to-earnings ratio of -3.77. Daré Bioscience, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 6th, 2024 based on prior year's report dates.
Daré Bioscience, Inc. Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
08/12/2024 | Q2 2024 | -$0.57 | $1.53 | 2.1 | $7.86 M | $22,438 |
03/29/2024 | Q1 2024 | -$0.81 | $9,302 | |||
12/29/2023 | Q4 2023 | -$0.69 | $1.81 M | |||
11/09/2023 | Q3 2023 | -$0.10 | -$1.09 | -0.99 | $733,333 | $1.00 M |
08/10/2023 | Q2 2023 | -$0.10 | -$1.22 | -1.12 | $1.10 M | $0 |
05/11/2023 | Q1 2023 | -$0.10 | -$1.13 | -1.03 | $0 | |
03/30/2023 | Q4 2022 | -$0.15 | -$2.34 | -2.19 | $10.00 B | |
11/10/2022 | Q3 2022 | -$0.11 | -$0.98 | -0.87 | $7.96 M | $0 |
08/09/2022 | Q2 2022 | $0.00 | $0.00 | 0 | $10.00 M | $10.00 M |
05/12/2022 | Q1 2022 | -$0.14 | -$0.10 | 0.04 | $0 | |
03/31/2022 | Q4 2021 | -$0.21 | -$0.13 | 0.08 | $0 | |
11/10/2021 | Q3 2021 | -$0.11 | -$0.18 | -0.07 | $5.73 M | $0 |
08/12/2021 | Q2 2021 | -$0.15 | -$0.18 | -0.03 | $0 | |
05/13/2021 | Q1 2021 | -$0.23 | -$0.16 | 0.07 | $0 | |
03/30/2021 | Q4 2020 | -$0.20 | -$0.27 | -0.07 | $0 | |
11/12/2020 | Q3 2020 | -$0.15 | -$0.24 | -0.09 | $304,333 | $0 |
08/12/2020 | Q2 2020 | -$0.14 | -$0.27 | -0.13 | $277,667 | $0 |
05/14/2020 | Q1 2020 | -$0.34 | -$0.18 | 0.16 | $0 | |
03/27/2020 | Q4 2019 | -$0.16 | $0 | |||
11/12/2019 | Q3 2019 | -$0.20 | $0 |
Daré Bioscience, Inc. Earnings: Frequently Asked Questions
-
When is Daré Bioscience, Inc.'s earnings date?
Daré Bioscience, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 6th, 2024 based off last year's report dates.
-
Did Daré Bioscience, Inc. beat their earnings estimates last quarter?
In the previous quarter, Daré Bioscience, Inc. (:DARE) reported $1.52 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.57 by $2.09.
-
How can I listen to Daré Bioscience, Inc.'s earnings conference call?
The conference call for Daré Bioscience, Inc.'s latest earnings report can be listened to online.
-
How can I read Daré Bioscience, Inc.'s conference call transcript?
The conference call transcript for Daré Bioscience, Inc.'s latest earnings report can be read online.
-
How much revenue does Daré Bioscience, Inc. generate each year?
Daré Bioscience, Inc. (:DARE) has a recorded annual revenue of $2.81 M.
-
How much profit does Daré Bioscience, Inc. generate each year?
Daré Bioscience, Inc. (:DARE) has a recorded net income of $2.81 M. Daré Bioscience, Inc. has generated $-4.15 earnings per share over the last four quarters.
-
What is Daré Bioscience, Inc.'s price-to-earnings ratio?
Daré Bioscience, Inc. (:DARE) has a price-to-earnings ratio of -3.77 and price/earnings-to-growth ratio is -0.69.